Literature DB >> 30298201

Functional MRI and delay discounting in patients infected with hepatitis C.

Holly McCready1,2,3, Milky Kohno1,2,3, Michael Kolessar1,4, Laura Dennis1,2,3, Daniel Kriz1, Hannah Luber1, Renee Anderson1, Michael Chang1,5, Anna Sasaki1,5, Kenneth Flora6, Arthur Vandenbark1,7,8, Suzanne H Mitchell2,3,9, Jennifer M Loftis1,3,5, William F Hoffman1,2,3,10, Marilyn Huckans11,12,13,14.   

Abstract

Hepatitis C virus-infected (HCV+) adults evidence increased rates of psychiatric and cognitive difficulties. This is the first study to use functional magnetic resonance imaging (fMRI) to examine brain activation in untreated HCV+ adults. To determine whether, relative to non-infected controls (CTLs), HCV+ adults exhibit differences in brain activation during a delay discounting task (DDT), a measure of one's tendency to choose smaller immediate rewards over larger delayed rewards-one aspect of impulsivity. Twenty adults with HCV and 26 CTLs completed an fMRI protocol during the DDT. Mixed effects regression analyses of hard versus easy trials of the DDT showed that, compared with CTLs, the HCV+ group exhibited less activation in the left lateral occipital gyrus, precuneus, and superior frontal gyrus. There were also significant interactive effects for hard-easy contrasts in the bilateral medial frontal gyrus, left insula, left precuneus, left inferior parietal lobule, and right temporal occipital gyrus; the CTL group evidenced a positive relationship between impulsivity and activation, while the HCV+ group exhibited a negative relationship. Within the HCV+ group, those with high viral load chose immediate rewards more often than those with low viral load, regardless of choice difficulty; those with low viral load chose immediate rewards more often on hard choices relative to easy choices. Results show that HCV+ patients exhibit greater impulsive behavior when presented with difficult choices, and impulsivity is negatively related to activation in regions important for cognitive control. Thus, interventions that decrease impulsive choice may be warranted with some HCV+ patients.

Entities:  

Keywords:  Cognition; Delay discounting; Hepatitis; Impulsivity; Neuroimaging; fMRI

Mesh:

Year:  2018        PMID: 30298201      PMCID: PMC6279508          DOI: 10.1007/s13365-018-0670-0

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  74 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

Review 2.  A review of delay-discounting research with humans: relations to drug use and gambling.

Authors:  Brady Reynolds
Journal:  Behav Pharmacol       Date:  2006-12       Impact factor: 2.293

3.  Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Authors:  William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

4.  Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients.

Authors:  Alexis P Chidi; Cindy L Bryce; Julie M Donohue; Michael J Fine; Douglas P Landsittel; Larissa Myaskovsky; Shari S Rogal; Galen E Switzer; Allan Tsung; Kenneth J Smith
Journal:  Value Health       Date:  2016-03-24       Impact factor: 5.725

Review 5.  Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

Authors:  Luigi Elio Adinolfi; Riccardo Nevola; Giacomo Lus; Luciano Restivo; Barbara Guerrera; Ciro Romano; Rosa Zampino; Luca Rinaldi; Ausilia Sellitto; Mauro Giordano; Aldo Marrone
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 6.  Impulsivity as a determinant and consequence of drug use: a review of underlying processes.

Authors:  Harriet de Wit
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

Review 7.  Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.

Authors:  Ivan Gentile; Alberto E Maraolo; Massimo Niola; Vincenzo Graziano; Guglielmo Borgia; Mariano Paternoster
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-09-16       Impact factor: 3.869

Review 8.  Neuroimaging and biomarkers in addiction treatment.

Authors:  Kathleen A Garrison; Marc N Potenza
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

9.  Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits.

Authors:  Karen D Ersche; Abigail J Turton; Shachi Pradhan; Edward T Bullmore; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2010-08-01       Impact factor: 13.382

10.  Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients.

Authors:  Joanna Bladowska; Brygida Knysz; Anna Zimny; Krzysztof Małyszczak; Anna Kołtowska; Paweł Szewczyk; Jacek Gąsiorowski; Michał Furdal; Marek J Sąsiadek
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more
  2 in total

1.  Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders.

Authors:  Ana Marques; Daniel Roquet; Elie Matar; Natasha Louise Taylor; Bruno Pereira; Claire O'Callaghan; Simon J G Lewis
Journal:  J Neurol       Date:  2021-03-11       Impact factor: 4.849

Review 2.  Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations.

Authors:  Matteo Tagliapietra; Salvatore Monaco
Journal:  Int J Mol Sci       Date:  2020-04-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.